↓ Skip to main content

Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled…

Overview of attention for article published in Lancet Oncology, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Citations

dimensions_citation
150 Dimensions

Readers on

mendeley
138 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial
Published in
Lancet Oncology, March 2013
DOI 10.1016/s1470-2045(13)70067-6
Pubmed ID
Authors

Olivier Richel, Henry JC de Vries, Carel JM van Noesel, Marcel GW Dijkgraaf, Jan M Prins

Abstract

Anal cancer is an increasing issue in HIV-positive men who have sex with men (MSM). Screening for its precursor, anal intraepithelial neoplasia (AIN), is subject of discussion. Current treatment options are suboptimum and have not been compared in a prospective trial. We compared efficacy and side-effects of imiquimod, topical fluorouracil, and electrocautery for the treatment of AIN.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
Unknown 136 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 13%
Student > Doctoral Student 16 12%
Other 12 9%
Student > Bachelor 12 9%
Student > Postgraduate 11 8%
Other 37 27%
Unknown 32 23%
Readers by discipline Count As %
Medicine and Dentistry 68 49%
Social Sciences 6 4%
Agricultural and Biological Sciences 5 4%
Psychology 4 3%
Nursing and Health Professions 3 2%
Other 11 8%
Unknown 41 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2023.
All research outputs
#1,852,788
of 25,374,647 outputs
Outputs from Lancet Oncology
#1,947
of 6,882 outputs
Outputs of similar age
#14,685
of 209,694 outputs
Outputs of similar age from Lancet Oncology
#27
of 110 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,882 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.